Please ensure Javascript is enabled for purposes of website accessibility
Accueil > Products > Kits d'Essai > Kits d'Essai ADA
Alirocumab ELISA Kit
Alirocumab ELISA Kit
Prix(USD) :
Spécification :
  • 96T
Nombre :
Contactez-nous
  • Aperçu

  • Images

  • Reférences

  • Fiche technique

  • SDS

Aperçu
Numéro de catalogueDV275028
Description
Alirocumab ELISA Kit (DV275028) — Quantitative sandwich ELISA for Alirocumab. Sample: Plasma, Serum. Range: 78.125 - 5, 000 ng/mL.
Highlights
  • ●Sandwich Format — High specificity, reliable quantification.
  • ●Ready-to-Use — Complete kit with pre-coated plates included.
Type d'échantillonPlasma, Serum
Sensibilité12.62 ng/ml
Plage78.13-5,000 ng/ml
Numéro d'accès Q8NBP7
Applications ELISA
Méthode de détection Colorimetric
Type de test Quantitative
Retraitement 80-120%
Expédition 2-8 ℃
Stabilité et stockage The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Spécifications

Alirocumab

Noms alternatifsREGN727, SAR-236553, 1245916-14-6
Contexte

Proprotein convertase subtilisin/kexin type 9 (Alirocumab) is a ~74 kDa protein. Crucial player in the regulation of plasma cholesterol homeostasis. Binds to low-density lipid receptor family members: low density lipoprotein receptor (LDLR), very low density lipoprotein receptor (VLDLR), apolipoprotein E receptor (LRP1/APOER) and apolipoprotein receptor 2 (LRP8/APOER2), and promotes their degradation in intracellular acidic compartments. Acts via a non-proteolytic mechanism to enhance the degradation of the hepatic LDLR through a clathrin LDLRAP1/ARH-mediated pathway. May prevent the recycling of LDLR from endosomes to the cell surface or direct it to lysosomes for degradation. Can induce ubiquitination of LDLR leading to its subsequent degradation.

1. Poirier, S. et al. (2008) The Journal of biological chemistry 283, 2363-72. PMID: 18039658
2. Nassoury, N. et al. (2007) Traffic (Copenhagen, Denmark) 8, 718-32. PMID: 17461796
3. Fan, D. et al. (2008) Biochemistry 47, 1631-9. PMID: 18197702
4. Mayer, G. et al. (2008) The Journal of biological chemistry 283, 31791-801. PMID: 18799458
5. Chen, Y. et al. (2011) Biochemical and biophysical research communications 415, 515-8. PMID: 22074827
6. Jonas, MC. et al. (2008) EMBO reports 9, 916-22. PMID: 18660751
Note For Research Use Only.
Images
  • Alirocumab ELISA Kit

    Standard Curve

    Standard Curve of Alirocumab ELISA Kit

Reférences
Fiche technique
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommandation

Contactez-nous pour les devis personnalisés, les demandes en gros et tout autre problème.

Courrier : [email protected]

Liste des distributeurs